☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Interview: PolyPid’s Dikla Czaczkes Akselbrad Shares Insights on the P-III (SHIELD I) Trial of D-PLEX100
February 16, 2022
GBT’s Oxbryta (voxelotor) Receives EC’s Approval for the Treatment of Hemolytic Anemia in Patients with Sickle Cell Disease
February 16, 2022
Cytokinetics Presents Results of Omecamtiv Mecarbil in P-III (METEORIC-HF) Trial for Heart Failure with Reduced Ejection Fraction...
February 16, 2022
HOOKIPA Entered into an Amended and Restated Collaboration and License Agreement with Gilead to Develop Arenaviral Immunotherapies...
February 16, 2022
BMS & Exelixis Present Two Years Follow-Up Results of Opdivo (nivolumab) + Cabometyx (cabozantinib) in P-III (CheckMate -9ER) Tria...
February 16, 2022
Intellia Signs a License and Collaboration Agreement with ONK to Advance Allogeneic CRISPR-Edited NK Cell Therapies for Cancer
February 16, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions